Bone Volume Deficiency
Bone Volume Deficiency - Related Videos
08:49
Models of Bone Metastasis
0 Views •
Cited by 115 •
2012
Animal models are frequently utilized to study cancer metastasis to bone. In this protocol we will describe two common methods of tumor inoculation for bone metastasis studies and briefly describe some of the analyses utilized to monitor and quantify these models.
01:30
Capital Deficiency in Liquidation: I
0 Views •
2026
During the liquidation of a partnership, a capital deficiency occurs when a partner’s capital account becomes negative after accounting for allocated losses and the payment of liabilities. Resolving such deficiencies is a critical step before the remaining assets can be distributed. However, complications arise when a partner is unable or unwilling to contribute additional funds to eliminate their deficiency.In cases where a partner cannot satisfy their capital deficiency, the loss must be...
04:55
A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse
0 Views •
Cited by 11 •
2016
The following article provides an easy, reproducible technique to effectively create a sustainable mouse model of limbal stem cell deficiency (LSCD). This animal model is useful in testing and comparing the efficacy of treatments for limbal stem cell diseases.
09:44
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
0 Views •
2025
This protocol demonstrates how the Src homology 2 domain-containing 5'-inositol phosphatase (SHIP)-deficient mouse model of Crohn disease (CD)-like ileal inflammation and fibrosis can be used to test novel therapeutics for CD.
01:25
Capital Deficiency in Liquidation: II
0 Views •
2026
A capital deficiency occurs when a partner's capital account has a debit balance during partnership liquidation. It may result from operating losses, excessive drawings, or losses from the sale of partnership assets. During liquidation, noncash assets are sold, liabilities are paid, gains or losses are allocated to the partners, and the remaining cash is distributed based on the partners' capital balances.Example: Ace Company decides to liquidate because it is nearing bankruptcy. Noncash assets...
FAQs
The central process is a shift in which bone resorption exceeds bone formation. Tooth loss, trauma, infection, disease, and prolonged disuse are identified contributors to this imbalance. As tissue is removed faster than it is replaced, the available structure may become less suitable for normal function, healing, or later medical reconstruction.
Bone volume deficiency can affect different structural dimensions rather than appearing as one uniform defect. Loss of height, width, or density changes the amount and quality of tissue available for support. Clinicians therefore need to characterize the local deficiency before selecting a reconstructive approach or determining whether subsequent interventions, including implant placement, are feasible.
The underlying cause and the condition of nearby tissues help determine how predictable healing and reconstruction may be. A defect associated with infection, trauma, disease, or disuse may present different planning concerns than one following tooth loss. Evaluating these circumstances supports a treatment strategy matched to the defect rather than applying the same approach to every patient.
Evaluation begins with clinical examination and imaging to identify the defect and determine the available bone. These assessments help reveal whether the main limitation concerns height, width, density, or overall structural support. The resulting information guides decisions about reconstruction and helps clinicians judge whether later procedures, such as implant placement, can be supported.
Bone grafting, guided bone regeneration, or another reconstructive approach may be considered when insufficient structural volume limits healing, normal function, or planned medical reconstruction. The choice depends on the identified deficiency, its cause, and local tissue conditions. These procedures aim to restore volume so that subsequent interventions become more feasible and stable.
The problem has applications across oral surgery, orthopedics, and regenerative medicine. In oral care, reduced volume can complicate reconstruction and implant placement. In broader medical practice, restoring deficient structure may support normal anatomy, function, or healing. Its relevance therefore extends beyond a single procedure and includes planning for several forms of tissue reconstruction.